Bruker Corp (BRKR) stock
Close on Nov 11, 2026Market cap $9.68BP/E –Yield –
Bruker Corp grew revenue 2.2% to $3.51B over the twelve months to Sep 30, 2026. Operating income fell 209.1% to -$69.80M, moving the operating margin from 1.9% to -2.0%. Free cash flow was $244.70M. At the latest close the market valued the company at $9.68B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $9.68B
- P/E ratio
- –
- Price to sales
- 2.76
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 2.53%
Fundamentals
- Revenue
- $3.51B
- Net income
- -$123.40M
- EPS, diluted
- -$1.10
- Free cash flow
- $244.70M
- Diluted shares
- 153M
Trading
- Next earnings
- Feb 11, 2027 (estimated, before the open)
- Previous close
- $62.24
- Open
- $63.68
- Day's range
- $61.96 – $64.28
- Volume
- 2,470,759
- Average volume (20 days)
- 2,633,885
- Index membership
- S&P MidCap 400 (since Feb 2022), Russell 1000, Russell 3000
- Beta (5 years)
- 1.07
- 52-week range
- $32.37 – $68.98
- RSI (14 days)
- 53.9
- Volatility (1 year)
- 59.6%
- Relative volume
- 1.07×
- WACC
- 9.3%
On 1 of our idea list: Superinvestor favorites
Index membership is inferred from the holdings of funds that track each index (IJH, SPMD, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BRKR | S&P 500 | Difference | BRKR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +6.1% | -2.4% | +8.5 pts | ||
| 3 months | +9.5% | -1.2% | +10.7 pts | ||
| Year to date | +32.9% | +12.3% | +20.6 pts | ||
| 1 year | +50.2% | +12.4% | +37.7 pts | ||
| 3 years | +9.2% | +78.8% | −69.6 pts | +3.0% | +21.4% |
| 5 years | -22.7% | +75.2% | −97.9 pts | -5.0% | +11.9% |
| 10 years | +183.7% | +311.1% | −127.4 pts | +11.0% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Bruker filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Results
- Results
- Results
- Results
About Bruker
Laboratory Analytical Instruments
Bruker develops, manufactures, and distributes high-performance scientific instruments alongside analytical and diagnostic solutions. Its technology platforms span magnetic resonance, mass spectrometry, chromatography, X-ray systems, microscopy, metrology, and molecular spectroscopy. The company organizes its business into four reportable segments: BSI BioSpin, BSI CALID, BSI NANO, and BEST. These offerings serve customers across life science and materials research, biopharmaceuticals, clinical microbiology, molecular diagnostics, nanotechnology, and industrial applied markets, including academic institutions, government bodies, healthcare providers, and commercial enterprises.
Company profile, executives and historyBruker stock: common questions
What is Bruker's stock price?
BRKR closed at $62.41 on Nov 11, 2026, up 0.27% on the day. Over the past 52 weeks it traded between $32.37 and $68.98.
What is Bruker's market cap?
Bruker was worth $9.68B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is BRKR's P/E ratio?
Bruker lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.10), so it has no meaningful P/E ratio.
How much revenue does Bruker make?
Bruker reported revenue of $3.51B for the twelve months to Sep 30, 2026, up 2.2% from a year earlier.
Does Bruker pay a dividend?
No. Bruker has not paid a cash dividend over the last twelve months.
When does Bruker report earnings next?
Bruker is expected to report Q4 FY2026 results on Feb 11, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has BRKR stock performed over the past year?
Including dividends, BRKR returned +50.2% over the past year, against +12.4% for the S&P 500.
Who are Bruker's competitors?
Companies most similar to Bruker by business, industry and size include WAT, BIO, RVTY, MTD, ILMN.
See a number that looks wrong?